- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-3-3-3-mer
- Ligands
- 3 x NAG- NAG- BMA- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 15 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG-NAG.2: 6 residues within 4Å:- Chain A: T.98, Q.100, S.120, F.121, N.122, K.133
No protein-ligand interaction detected (PLIP)NAG-NAG.9: 6 residues within 4Å:- Chain A: N.332, S.333, S.334, S.357
- Ligands: NAG-NAG.10, NAG-NAG.10
No protein-ligand interaction detected (PLIP)NAG-NAG.10: 5 residues within 4Å:- Chain A: N.355, S.357
- Ligands: NAG-NAG.9, NAG-NAG.9, NAG-NAG.11
No protein-ligand interaction detected (PLIP)NAG-NAG.11: 4 residues within 4Å:- Chain A: S.357, N.361
- Ligands: NAG-NAG.10, NAG-NAG.10
No protein-ligand interaction detected (PLIP)NAG-NAG.12: 6 residues within 4Å:- Chain A: N.232, L.235, P.261, V.414, N.416
- Ligands: NAG-NAG-BMA-MAN-MAN-MAN-MAN.4
No protein-ligand interaction detected (PLIP)NAG-NAG.14: 6 residues within 4Å:- Chain E: T.98, Q.100, S.120, F.121, N.122, K.133
No protein-ligand interaction detected (PLIP)NAG-NAG.21: 5 residues within 4Å:- Chain E: N.332, S.333, S.357
- Ligands: NAG-NAG.22, NAG-NAG.22
No protein-ligand interaction detected (PLIP)NAG-NAG.22: 5 residues within 4Å:- Chain E: N.355, S.357
- Ligands: NAG-NAG.21, NAG-NAG.21, NAG-NAG.23
No protein-ligand interaction detected (PLIP)NAG-NAG.23: 4 residues within 4Å:- Chain E: S.357, N.361
- Ligands: NAG-NAG.22, NAG-NAG.22
No protein-ligand interaction detected (PLIP)NAG-NAG.24: 6 residues within 4Å:- Chain E: N.232, L.235, P.261, V.414, N.416
- Ligands: NAG-NAG-BMA-MAN-MAN-MAN-MAN.16
No protein-ligand interaction detected (PLIP)NAG-NAG.26: 6 residues within 4Å:- Chain I: T.98, Q.100, S.120, F.121, N.122, K.133
No protein-ligand interaction detected (PLIP)NAG-NAG.33: 5 residues within 4Å:- Chain I: N.332, S.333, S.357
- Ligands: NAG-NAG.34, NAG-NAG.34
No protein-ligand interaction detected (PLIP)NAG-NAG.34: 5 residues within 4Å:- Chain I: N.355, S.357
- Ligands: NAG-NAG.33, NAG-NAG.33, NAG-NAG.35
No protein-ligand interaction detected (PLIP)NAG-NAG.35: 4 residues within 4Å:- Chain I: S.357, N.361
- Ligands: NAG-NAG.34, NAG-NAG.34
No protein-ligand interaction detected (PLIP)NAG-NAG.36: 6 residues within 4Å:- Chain I: N.232, L.235, P.261, V.414, N.416
- Ligands: NAG-NAG-BMA-MAN-MAN-MAN-MAN.28
No protein-ligand interaction detected (PLIP)- 15 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA.3: 7 residues within 4Å:- Chain A: V.144, R.162, N.167
- Chain I: R.278
- Chain K: S.25, G.26, F.28
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.5: 3 residues within 4Å:- Chain A: N.246, T.248, N.249
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.6: 7 residues within 4Å:- Chain A: Q.263, N.265, N.301, S.303, R.412, V.414
- Ligands: NAG-NAG-BMA.8
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.7: 8 residues within 4Å:- Chain A: N.271, I.292, Q.408
- Chain D: D.1, Q.27, Y.92, D.93, S.94
1 PLIP interactions:1 interactions with chain D- Hydrogen bonds: D:S.94
NAG-NAG-BMA.8: 7 residues within 4Å:- Chain A: T.267, H.299, N.301, S.381, T.383, R.412
- Ligands: NAG-NAG-BMA.6
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.15: 7 residues within 4Å:- Chain A: R.278
- Chain C: S.25, G.26, F.28
- Chain E: V.144, R.162, N.167
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.17: 3 residues within 4Å:- Chain E: N.246, T.248, N.249
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.18: 7 residues within 4Å:- Chain E: Q.263, N.265, N.301, S.303, R.412, V.414
- Ligands: NAG-NAG-BMA.20
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.19: 8 residues within 4Å:- Chain E: N.271, I.292, Q.408
- Chain H: D.1, Q.27, Y.92, D.93, S.94
1 PLIP interactions:1 interactions with chain H- Hydrogen bonds: H:S.94
NAG-NAG-BMA.20: 7 residues within 4Å:- Chain E: T.267, H.299, N.301, S.381, T.383, R.412
- Ligands: NAG-NAG-BMA.18
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.27: 7 residues within 4Å:- Chain E: R.278
- Chain G: S.25, G.26, F.28
- Chain I: V.144, R.162, N.167
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.29: 3 residues within 4Å:- Chain I: N.246, T.248, N.249
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.30: 7 residues within 4Å:- Chain I: Q.263, N.265, N.301, S.303, R.412, V.414
- Ligands: NAG-NAG-BMA.32
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.31: 8 residues within 4Å:- Chain I: N.271, I.292, Q.408
- Chain L: D.1, Q.27, Y.92, D.93, S.94
1 PLIP interactions:1 interactions with chain L- Hydrogen bonds: L:S.94
NAG-NAG-BMA.32: 7 residues within 4Å:- Chain I: T.267, H.299, N.301, S.381, T.383, R.412
- Ligands: NAG-NAG-BMA.30
No protein-ligand interaction detected (PLIP)- 3 x NAG- NAG- BMA- MAN- MAN- MAN- MAN: alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA-MAN-MAN-MAN-MAN.4: 20 residues within 4Å:- Chain A: E.181, P.182, L.231, N.232, F.345, N.346, G.348, I.407, Q.408, G.409, V.410, I.411, R.412, C.413, V.414, S.415
- Chain C: H.59
- Chain D: S.94, R.95
- Ligands: NAG-NAG.12
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN-MAN-MAN-MAN.16: 20 residues within 4Å:- Chain E: E.181, P.182, L.231, N.232, F.345, N.346, G.348, I.407, Q.408, G.409, V.410, I.411, R.412, C.413, V.414, S.415
- Chain G: H.59
- Chain H: S.94, R.95
- Ligands: NAG-NAG.24
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN-MAN-MAN-MAN.28: 20 residues within 4Å:- Chain I: E.181, P.182, L.231, N.232, F.345, N.346, G.348, I.407, Q.408, G.409, V.410, I.411, R.412, C.413, V.414, S.415
- Chain K: H.59
- Chain L: S.94, R.95
- Ligands: NAG-NAG.36
No protein-ligand interaction detected (PLIP)- 21 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.37: 4 residues within 4Å:- Chain A: E.57, N.58
- Chain B: F.8, S.17
Ligand excluded by PLIPNAG.38: 1 residues within 4Å:- Chain A: N.103
Ligand excluded by PLIPNAG.39: 1 residues within 4Å:- Chain A: N.107
Ligand excluded by PLIPNAG.40: 2 residues within 4Å:- Chain A: N.204, S.244
Ligand excluded by PLIPNAG.41: 2 residues within 4Å:- Chain A: N.308, W.364
Ligand excluded by PLIPNAG.42: 1 residues within 4Å:- Chain A: N.324
Ligand excluded by PLIPNAG.43: 3 residues within 4Å:- Chain D: G.16, N.18, K.76
Ligand excluded by PLIPNAG.44: 4 residues within 4Å:- Chain E: E.57, N.58
- Chain F: F.8, S.17
Ligand excluded by PLIPNAG.45: 1 residues within 4Å:- Chain E: N.103
Ligand excluded by PLIPNAG.46: 1 residues within 4Å:- Chain E: N.107
Ligand excluded by PLIPNAG.47: 2 residues within 4Å:- Chain E: N.204, S.244
Ligand excluded by PLIPNAG.48: 2 residues within 4Å:- Chain E: N.308, W.364
Ligand excluded by PLIPNAG.49: 1 residues within 4Å:- Chain E: N.324
Ligand excluded by PLIPNAG.50: 3 residues within 4Å:- Chain H: G.16, N.18, K.76
Ligand excluded by PLIPNAG.51: 4 residues within 4Å:- Chain I: E.57, N.58
- Chain J: F.8, S.17
Ligand excluded by PLIPNAG.52: 1 residues within 4Å:- Chain I: N.103
Ligand excluded by PLIPNAG.53: 1 residues within 4Å:- Chain I: N.107
Ligand excluded by PLIPNAG.54: 2 residues within 4Å:- Chain I: N.204, S.244
Ligand excluded by PLIPNAG.55: 2 residues within 4Å:- Chain I: N.308, W.364
Ligand excluded by PLIPNAG.56: 1 residues within 4Å:- Chain I: N.324
Ligand excluded by PLIPNAG.57: 3 residues within 4Å:- Chain L: G.16, N.18, K.76
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Chan, K.W. et al., A site of vulnerability at V3 crown defined by HIV-1 bNAb M4008_N1. Nat Commun (2021)
- Release Date
- 2021-11-17
- Peptides
- Envelope glycoprotein gp160: AEI
HIV-1 Envelope Glycoprotein BG505 SOSIP.664 gp41: BFJ
M4008_N1 Fab heavy chain: CGK
M4008_N1 Fab light chain: DHL - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AE
CI
EB
BF
DJ
FC
HG
IK
JD
LH
ML
N
SMTL ID : 7rai.1
Cryo-EM structure of M4008_N1 Fab in complex with BG505 DS-SOSIP.664 Env trimer
Envelope glycoprotein gp160
Toggle Identical (AEI)HIV-1 Envelope Glycoprotein BG505 SOSIP.664 gp41
Toggle Identical (BFJ)M4008_N1 Fab heavy chain
Toggle Identical (CGK)M4008_N1 Fab light chain
Toggle Identical (DHL)Related Entries With Identical Sequence
4tvp.1 | 4zmj.1 | 5aco.1 | 5c7k.1 | 5cez.2 | 5cjx.1 | 5fyl.1 | 5t3x.1 | 5t3z.1 | 5thr.1 | 5u7m.1 | 5u7o.1 | 5utf.1 | 5uty.1 | 5v7j.1 | 5v8l.1 | 5v8m.1 | 5viy.1 | 5vj6.1 | 5w6d.1 | 6cm3.1 | 6crq.1 | 6de7.1 | 6did.1 | 6mn7.1 | 6mtj.1 | 6mtn.1 | 6mu6.1 | 6mu7.1 | 6mu8.1 more...less...6nf2.1 | 6nm6.1 | 6nnf.1 | 6nnj.1 | 6opa.1 | 6osy.1 | 6ot1.1 | 6oz4.1 | 6ozc.1 | 6pw6.1 | 6u0l.1 | 6u0n.1 | 6udj.1 | 6vi0.1 | 6vn0.1 | 6w03.1 | 6x96.1 | 6x97.1 | 6x98.1 | 6x9r.1 | 6x9r.2 | 6x9r.3 | 6x9s.1 | 6x9s.2 | 6x9s.3 | 6x9t.1 | 6x9t.2 | 6x9t.3 | 6x9u.1 | 6x9u.2 | 6x9u.3 | 6x9v.1 | 6x9v.2 | 6x9v.3 | 6xrt.1 | 7kde.1 | 7lo6.1 | 7lok.1 | 7lpn.1 | 7mxe.1 | 7pc2.1 | 7tfn.1 | 7tfo.1 | 7txd.1 | 7ucf.1 | 7uoj.1 | 8dp1.1 | 8dto.1 | 8e1p.1 | 8euu.1 | 8euv.1 | 8euw.1 | 8fis.1 | 8fk5.1 | 8fl1.1 | 8flw.1 | 8fyj.1 | 8g85.1 | 8g9w.1 | 8g9x.1 | 8g9y.1 | 8gas.1 | 8jtd.1 | 8jtm.1 | 8sal.1 | 8san.1 | 8saq.1 | 8sat.1 | 8sav.1 | 8sw3.1 | 8sw4.1 | 8tjr.1 | 8tjs.1 | 8tkc.1 | 8tl2.1 | 8tl3.1 | 8tl4.1 | 8tl5.1 | 8tng.1 | 8tnh.1 | 8tni.1 | 8tnu.1 | 8to7.1 | 8top.1 | 8tq1.1 | 8ttw.1